FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386156763> ?p ?o ?g. }

• W4386156763 endingPage "e0289911" @default.
• W4386156763 startingPage "e0289911" @default.
• W4386156763 abstract "Attempts at personalisation of exercise programmes in head and neck cancer (HaNC) have been limited. The main aim of the present study is to investigate the feasibility and acceptability of introducing a remotely delivered, fully personalised, collaborative, and flexible approach to prescribing and delivering exercise programmes into the HaNC usual care pathway.This is a single arm, feasibility study. Seventy patients diagnosed with HaNC will be recruited from two regional HaNC centres in the United Kingdom. Patients will undertake an 8-week exercise programme designed and delivered by cancer exercise specialists. The exercise programme will start any time between the time of diagnosis and up to 8 weeks after completing treatment, depending on patient preference. The content of the exercise programme will be primarily based on patient needs, preferences, and goals, but guided by current physical activity guidelines for people with cancer. The primary outcome measure is retention to the study. Secondary quantitative outcomes are uptake to the exercise programme, different measures of exercise adherence, pre- and post-intervention assessments of fatigue (Multidimensional Fatigue Symptom Inventory-Short Form), quality of life (SF-36), physical activity levels (International Physical Activity Questionnaire-Short Form), and various components of physical fitness. The outcomes of the nested qualitative study are acceptability and feasibility of the intervention evaluated via interviews with patients, health care professionals, and the cancer exercise specialists. Intervention and participant fidelity will be determined using checklists and scrutiny of each patient's logbook and the cancer exercise specialists' meeting notes. Analysis of quantitative data will be via standard summary statistics. Qualitative data will be analysed using thematic analysis.This feasibility study will inform the design and conduct of a future randomised controlled trial. Success will be defined according to a traffic light system for identifying the appropriateness of progression to a randomised controlled trial.International Standard Randomised Controlled Trial Number registry (ISRCTN82505455)." @default.
• W4386156763 created "2023-08-26" @default.
• W4386156763 creator A5003113567 @default.
• W4386156763 creator A5003181752 @default.
• W4386156763 creator A5009028536 @default.
• W4386156763 creator A5012511694 @default.
• W4386156763 creator A5025307970 @default.
• W4386156763 creator A5050582071 @default.
• W4386156763 creator A5052361370 @default.
• W4386156763 creator A5053478732 @default.
• W4386156763 creator A5056766051 @default.
• W4386156763 creator A5057722298 @default.
• W4386156763 creator A5062151567 @default.
• W4386156763 creator A5084825146 @default.
• W4386156763 date "2023-08-25" @default.
• W4386156763 modified "2023-09-26" @default.
• W4386156763 title "ACTivity as medicine In Oncology for Head and Neck (ACTIOHN): Protocol for a feasibility study investigating a patient-centred approach to exercise for people with head and neck cancer" @default.
• W4386156763 cites W1963651936 @default.
• W4386156763 cites W1976770755 @default.
• W4386156763 cites W1979290264 @default.
• W4386156763 cites W1986071902 @default.
• W4386156763 cites W1986901843 @default.
• W4386156763 cites W1996704440 @default.
• W4386156763 cites W2013620493 @default.
• W4386156763 cites W2019857005 @default.
• W4386156763 cites W2025860296 @default.
• W4386156763 cites W2037243742 @default.
• W4386156763 cites W2069624259 @default.
• W4386156763 cites W2094854820 @default.
• W4386156763 cites W2118894860 @default.
• W4386156763 cites W2120612383 @default.
• W4386156763 cites W2127356661 @default.
• W4386156763 cites W2139994949 @default.
• W4386156763 cites W2141846678 @default.
• W4386156763 cites W2143342727 @default.
• W4386156763 cites W2144185507 @default.
• W4386156763 cites W2171129594 @default.
• W4386156763 cites W2171811563 @default.
• W4386156763 cites W2177834950 @default.
• W4386156763 cites W2179762566 @default.
• W4386156763 cites W2225480285 @default.
• W4386156763 cites W2239486811 @default.
• W4386156763 cites W2528071154 @default.
• W4386156763 cites W2560109088 @default.
• W4386156763 cites W2588182016 @default.
• W4386156763 cites W2618094628 @default.
• W4386156763 cites W2721111021 @default.
• W4386156763 cites W2739751169 @default.
• W4386156763 cites W2740506427 @default.
• W4386156763 cites W2745763510 @default.
• W4386156763 cites W2761567807 @default.
• W4386156763 cites W2765724632 @default.
• W4386156763 cites W2782723235 @default.
• W4386156763 cites W2800543167 @default.
• W4386156763 cites W2899908418 @default.
• W4386156763 cites W2910411436 @default.
• W4386156763 cites W2923336787 @default.
• W4386156763 cites W2943927029 @default.
• W4386156763 cites W2944366756 @default.
• W4386156763 cites W2945994995 @default.
• W4386156763 cites W2978104138 @default.
• W4386156763 cites W2981263606 @default.
• W4386156763 cites W2998202711 @default.
• W4386156763 cites W3012130668 @default.
• W4386156763 cites W3038480811 @default.
• W4386156763 cites W3109283673 @default.
• W4386156763 cites W3128646645 @default.
• W4386156763 cites W3192357364 @default.
• W4386156763 cites W3194211469 @default.
• W4386156763 cites W3201277847 @default.
• W4386156763 cites W4232698832 @default.
• W4386156763 cites W4232732194 @default.
• W4386156763 cites W4242883546 @default.
• W4386156763 cites W4312210175 @default.
• W4386156763 doi "https://doi.org/10.1371/journal.pone.0289911" @default.
• W4386156763 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37624789" @default.
• W4386156763 hasPublicationYear "2023" @default.
• W4386156763 type Work @default.
• W4386156763 citedByCount "0" @default.
• W4386156763 crossrefType "journal-article" @default.
• W4386156763 hasAuthorship W4386156763A5003113567 @default.
• W4386156763 hasAuthorship W4386156763A5003181752 @default.
• W4386156763 hasAuthorship W4386156763A5009028536 @default.
• W4386156763 hasAuthorship W4386156763A5012511694 @default.
• W4386156763 hasAuthorship W4386156763A5025307970 @default.
• W4386156763 hasAuthorship W4386156763A5050582071 @default.
• W4386156763 hasAuthorship W4386156763A5052361370 @default.
• W4386156763 hasAuthorship W4386156763A5053478732 @default.
• W4386156763 hasAuthorship W4386156763A5056766051 @default.
• W4386156763 hasAuthorship W4386156763A5057722298 @default.
• W4386156763 hasAuthorship W4386156763A5062151567 @default.
• W4386156763 hasAuthorship W4386156763A5084825146 @default.
• W4386156763 hasBestOaLocation W43861567631 @default.
• W4386156763 hasConcept C111368507 @default.
• W4386156763 hasConcept C121608353 @default.
• W4386156763 hasConcept C126322002 @default.
• W4386156763 hasConcept C127313418 @default.
• W4386156763 hasConcept C142724271 @default.

• next